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Abstract
Background: Metabolic disorders are established precursors to cardiovascular diseases, yet they can be readily prevented with
sustained lifestyle modifications.
Objective: We assessed the effectiveness of a smartphone-based weight management app on metabolic parameters in adults at
high-risk, yet without physician diagnosis nor pharmacological treatment for metabolic syndrome, in a community setting.
Methods: In this 3-arm parallel-group, single-blind, randomized controlled trial, we recruited participants aged 30 to 59 years
with at least 2 conditions defined by the Third Report of the National Cholesterol Education Program expert panel (abdominal
obesity, high blood pressure, high triglycerides, low high-density lipoprotein cholesterol, and high fasting glucose level). Participants
were randomly assigned (1:1:1) by block randomization to either the nonuser group (control), the app-based diet and exercise
self-logging group (app only), or the app-based self-logging and personalized coaching from professional dieticians and exercise
coordinators group (app with personalized coaching). Assessments were performed at baseline, week 6, week 12, and week 24.
The primary outcome was change in systolic blood pressure (between baseline and follow-up assessments). Secondary outcomes
were changes in diastolic blood pressure, body weight, body fat mass, waist circumference, homeostatic model of assessment of
insulin resistance, triglyceride level, and high-density lipoprotein cholesterol level between baseline and follow-up assessments.
Analysis was performed using intention-to-treat.
Results: Between October 28, 2017 and May 28, 2018, 160 participants participated in the baseline screening examination.
Participants (129/160, 80.6%) who satisfied the eligibility criteria were assigned to control (n=41), app only (n=45), or app with
personalized coaching (n=43) group. In each group, systolic blood pressure showed decreasing trends from baseline (control:
mean –10.95, SD 2.09 mmHg; app only: mean –7.29, SD 1.83 mmHg; app with personalized coaching: mean –7.19, SD 1.66
mmHg), yet without significant difference among the groups (app only: P=.19; app with personalized coaching: P=.16). Instead,
those in the app with personalized coaching group had greater body weight reductions (control: mean –0.12, SD 0.30 kg; app
only: mean –0.35, SD 0.36 kg, P=.67; app with personalized coaching: mean –0.96, SD 0.37 kg; P=.08), specifically by body fat
mass reduction (control: mean –0.13, SD 0.34 kg; app only: mean –0.64, SD 0.38 kg, P=.22; app with personalized coaching:
mean –0.79, SD 0.38 kg; P=.08).
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Conclusions: Simultaneous diet and exercise self-logging and persistent lifestyle modification coaching were ineffective in
lowering systolic blood pressure but effective in losing weight and reducing body fat mass. These results warrant future
implementation studies of similar models of care on a broader scale in the context of primary prevention.
Trial Registration: ClinicalTrials.gov NCT03300271; http://clinicaltrials.gov/ct2/show/NCT03300271
(J Med Internet Res 2020;22(10):e17435) doi: 10.2196/17435
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Introduction
Metabolic disorders are established precursors to cardiovascular
disease [1]. Previous studies have demonstrated that even at
subclinical stages, persons with elevated blood pressure, blood
glucose level, cholesterol level, and adiposity are at significantly
higher risk of adverse cardiometabolic outcomes [2]. Despite
recent health care policy changes that have expanded healthy
lifestyle advocacy initiatives, a considerable proportion do not
achieve the guideline-recommended metabolic profile [3-5].
Therefore, timely and persistent management of metabolic
abnormalities are crucial in preventing adverse health outcomes
at an individual level and conserving substantial health care
costs at a national level.
Alongside the advent of new medicines, technological
innovations have aided in easing accessibility to and enriching
the quality of health care. They have eliminated practical
barriers, thereby allowing the distribution and improvement of
health care via nonconventional routes at unprecedented speeds
[6]. Several features include the transmission of medical records,
social media forums for open discussion, web-based interactive
education programs, higher precision diagnostics, real-time
status tracking, digitalized clinics (ie, telemonitoring), and
prescription dispensation [7,8].
In particular, the ubiquity of mobile phone technology has
incentivized industries to create smartphone-based apps for
health monitoring [9]. Previous trials [10,11] have evaluated
the efficacy and effectiveness of such tools in the context of
secondary prevention. For example, among patients receiving
cardiac rehabilitation after hospitalization for myocardial
infarction, daily text message reminders led to greater
medication adherence and exercise capacity compared with
patients receiving usual care [10]. The utility extends to general
populations; a Finnish trial [11] demonstrated both short- and
long-term weight loss among people who were overweight and
who logged weight daily and received dietary management
instructions over a period of 1 year. By collecting data in real
time, these mobile-based apps enable researchers to assess
multiple behaviors and to prompt change at low cost and with
high ease.
Nonetheless, there are important limitations in the current
literature. Previous studies [12-14] have primarily recruited
clinic patients who were already using or were exceptionally
motivated to use health management tools. Methodologically,
many studies [7] estimated the effect of these mobile
interventions based on per protocol analysis. It has been
established that physical activity and diet affect blood pressure
level not only in hypertension patients but also in people with
prehypertension or elevated blood pressure [15]. Recent blood
pressure guidelines [15,16] emphasized early lifestyle
modification for people whose blood pressure is above the
normal range. However, the effects of smartphone-based apps
in lowering blood pressure have not been properly assessed in
people whose blood pressure is above the normal range in
real-world settings.
In this context, the objective of the study was to evaluate the
longitudinal effect of smartphone-based health care app on
metabolic parameters in a sample of the general population with
moderate metabolic abnormalities yet without clinical diagnosis
nor pharmacological treatment. We hypothesized that the
participants receiving both real-time personalized coaching and
self-logging diet and physical activity would yield greater
improvements in blood pressure and other metabolic parameters




The study was designed as a single-blind 3-arm parallel-design
randomized controlled trial delivering a 6-month primary
prevention program via mobile app to a population with
moderate metabolic abnormalities with neither diagnosis nor
treatment for metabolic disorders. The main objective was to
evaluate the effectiveness of health management app on
metabolic parameters over 3 follow-up examinations.
Community-dwelling adults residing in Seoul and nearby capital
regions were recruited. The study protocol was approved by the
institutional review boards of Severance Hospital and Yonsei
University Health System (4-2017-0666), and the protocol of
the study is registered at ClinicalTrials.gov (NCT03300271).
Participants
Candidate participants were identified based on objectively
measured metabolic profiles from a previous Cardiovascular
and Metabolic Diseases Etiology Research Center (CMERC)
observational cohort study [17]. Briefly, the CMERC study [17]
aimed to identify novel risk factors and to investigate the
distribution and effects of known cardiovascular and metabolic
diseases risk factors.
We recruited smartphone users aged 30-59 years with at least
2 metabolic abnormalities defined by the modified version of
the Third Report of the National Cholesterol Education Program
expert panel on detection, evaluation, and treatment of high
blood cholesterol in adults [18] using the criteria for Asian
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populations: waist circumference (male: ≥90 cm; female: ≥80
cm), blood pressure (systolic: ≥135 mmHg; diastolic: ≥85
mmHg), triglyceride ≥150 mg/dL, high-density lipoprotein
(HDL) cholesterol (male: <40 mg/dL; female: <50 mg/dL), and
fasting glucose level ≥100 mg/dL. Exclusion criteria included
users of smartphone-based health care apps for lifestyle
modification, individuals with a previous diagnosis of
cardiovascular disease, malignant cancer, or metabolic
syndrome, individuals who were taking antihypertensives, lipid-
or glucose-lowering drugs, and women who were pregnant or
breastfeeding at the time of the study.
Among 3625 CMERC cohort participants [17], 546 people
qualified. We contacted these individuals via telephone and
mail for recruitment. Of the 160 (29.1%) who expressed
affirmative for screening test, a total of 129 participants (23.6%)
attended the baseline examination (Figure 1).
Participants were asked to give their written consent without
knowledge of the intervention assignments.
Figure 1. Flow diagram of the study participants. CMERC: Cardiovascular and Metabolic Diseases Etiology Research Center.
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We randomly allocated participants into 1 of the 3 intervention
arms via sex- and age-stratified block randomization.
Specifically, we set the block size equal to 6 from sex (male or
female) by age group in decile (30, 40, and 50) using R (version
3.4.4; R Foundation for Statistical Computing). We adopted a
single-blind approach; thus, the effectiveness would be assessed
by masked researchers unaware of the randomization results.
The allocation concealment was achieved via individualized
texting, which instructed all participants to adhere to their
respective intervention, to avoid using other health management
apps, and to refrain from sharing of their intervention
instructions with each other for the entire study duration. To
minimize crossover or contamination, we (1) retrospectively
ensured no unallocated feature had been installed to the app
only group from the app’s user-specific metadata and (2) asked
the participants whether they had engaged in other health-related
trials, programs, or apps at every follow-up assessment.
Procedures
At the baseline assessment, all participants received on-site
education that entailed information on metabolic syndrome and
preventive strategies, including validated exercise regimens and
nutritious cooking recipes. Then, we randomly allocated
participants into 1 of the 3 intervention arms: the control group
(control; n=41) received only the aforementioned baseline
education and was asked to refrain from concurrently engaging
in any smartphone-based lifestyle modification app or programs;
the app only (app only; n=45) and the app with personalized
coaching (app with personalized coaching; n=43) groups also
received the baseline education and were additionally asked to
use a smartphone-based weight management app called Noom
(Noom Inc). Specifically, Noom allows users to log details
regarding daily food intake and physical activities. For instance,
a user can record a specific menu item (ie, fastfood chain M’s
cheeseburger), consumed portion (ie, single serving, half of
cheeseburger), and time of consumption (ie, breakfast, 8 AM).
From Noom’s nutrition metadata, the app readily calculates
total calories and macronutrients consumed for each log entry.
Likewise, a wide array of physical activities (ie, indoor treadmill
walking) are available for selection from the predefined list.
After entering the intensity (ie, pace) and duration (ie, 60
minutes) of physical activity, the app yields energy expenditure
in kilocalories, accounting for the user’s sex, age, height, and
weight. As an additional feature, it delivers structured
health-related curricula and personalized feedback from certified
exercise regimen coordinators and clinical dieticians based on
their reviews of the user’s logs (Figure 2).
Figure 2. Example of personalized coaching.
The default frequency of personalized coaching was set to 3
times per week; however, the actual frequency varied depending
on the user’s participation rate. Only the app with personalized
coaching group received the personalized coaching. All users’
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activation statuses were evaluated based on the number of
weight, meal, and physical activity logs. Weekly, we defined
each user as active if the user had recorded at least 1
aforementioned parameter.
The universal baseline examination included anthropometric
measurements, blood tests, and face-to-face interviews on
demographics, disease history, and health behavior. Then,
participants received text messages notifying them of the study
initiation. The app only and app with personalized coaching
groups were given additional instructions regarding the Noom
app installation procedures; each user received a unique
identification code.
Outcomes
The primary outcome was change in systolic blood pressure
between the baseline and follow-up at 6, 12, and 24 weeks. The
secondary outcomes were changes in diastolic blood pressure,
body weight, body fat mass, waist circumference, homeostatic
model of assessment of insulin resistance (HOMA-IR), and
lipid profile (triglyceride and HDL cholesterol) between the
baseline and follow-up at 6, 12, and 24 weeks.
Anthropometric measurements were performed with strict
adherence to standardized protocols and using calibrated
equipment. Blood pressure was consecutively measured using
both single- and double-arm automated oscillometric devices
(HEM-7080, Omron Health; WatchBP Office Central, Microlife)
at a single sitting. The mean of second and third measurements
were used for analysis. Participants underwent blood tests after
overnight fasting for a minimum of 8 hours. Fasting plasma
glucose and insulin levels were assessed using colorimetry
method (ADVIA1800 Auto Analyzer, Siemens Medical
Solutions). HOMA-IR was calculated as the product of fasting
glucose and insulin levels divided by 405 in mg/dL. Weight
was measured to the nearest 0.1 kg on a digital scale (DB-150,
CAS). To minimize measurement variability, a zero-point
adjustment was routinely conducted using weight blocks (20,
40, and 60 kg). Bioelectrical impedance analysis delineated
body composition (BSM-330, INBODY). Waist circumference
was measured to the nearest 0.1 cm using a plastic tape (SECA
201, SECA), while maintaining the level of the measuring tape.
Physical activity was assessed by the Korean version of the
International Physical Activity Questionnaire [19]. Using
validated alcohol consumption and cigarette smoking ratings,
participants were divided into non-, previous-, and current
categories for alcohol consumption and smoking.
Statistical Analysis
The target sample size was 150 participants, chosen to provide
precise estimates of the intended effect of mobile app usage.
Specifically, the sample size calculation was conducted based
on the expected difference in systolic blood pressure after 24
weeks across the 3 intervention arms [20]. We assumed a
statistical power of 80% and a significance level of P<.05. Based
on previous literature [20,21], we expected a mean systolic
blood pressure difference of 6 mmHg with a standard deviation
of 10 mmHg after 24 weeks. When considering 10% attrition
rate and 3-arm design, the study required a minimum recruitment
of 150 participants.
We employed analysis of variance to assess differences in
demographic and health-related behavior. Then, we compared
the extent of changes in each metabolic parameter across
participants randomly assigned to control versus app only and
app with personalized coaching groups, separately, using an
intention-to-treat approach; all participants who participated in
at least 1 of the 3 follow-up assessment were included in the
analysis. We used independent t tests to evaluate the primary
and secondary outcomes at each time point. To account for
repeated measurements over multiple follow-ups, we employed
a linear mixed model to determine the effect of mobile health
care apps on the prespecified outcomes. Specifically, the
unstructured linear mixed model incorporates time and
group×time interaction terms to assume no homogeneity across
the 3 groups at the baseline. From the random intercept model,
the estimated beta coefficient of the group×time interaction
term was regarded as the effect of the app usage. The changes
are presented as estimated beta coefficient (β) and standard
error (SE). All statistical tests were 2-sided and the statistical
significance was set at a P<.05. All analyses were performed
using R and SAS (version 9.4; SAS Institute Inc).
All data were collected, registered, and managed on
ClinicalTrials.gov (NCT03300271). Data were deidentified and
accessible only by designated researchers. All researchers
strictly adhered to data security protocols. For unbiased data
monitoring and trial safety overseeing, the research director
delegated Dae Ryong Kang, a professor of biomedical data
science at Yonsei University, Wonju College of Medicine,




All participants were enrolled on October 28, 2017, and the last
participant completed the week 24 follow-up on June 2, 2018.
Of the 129 enrolled individuals, 41 (32%) were randomly
assigned to the control group, 45 (35%) to the app only group,
and 43 (33%) to the app with personalized coaching group
(Figure 1). In the end, 111 participants attended at least 1
follow-up examination (week 6: 107; week 12: 100; week 24:
105), yielding a 14.0% attrition rate overall.
Baseline Characteristics
Table 1 shows the general characteristics of the study
participants at the baseline screening. Overall, the participants
were similarly distributed in terms of age, metabolic parameters,
and health behaviors across the 3 groups. At baseline, systolic
blood pressure was comparable across the 3 groups (control:
mean 131.8 mmHg; app only: mean 130.8 mmHg; app with
personalized coaching: mean 133.3 mmHg). Such comparability
across the groups ensured the baseline differences did not affect
the changes in metabolic parameter over the study period.
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Table 1. General characteristics of the study participants at the baseline screening.
App+personalized coaching
(n=43)
App only (n=45)Control (n=41)Variables
48.9 (7.8)49.2 (7.5)49.5 (7.9)Age (years), mean (SD)
Sex, n (%)
21 (48.8)23 (51.1)19 (46.3)Male
22 (51.2)22 (49.9)22 (53.7)Female
2.8 (0.9)2.9 (0.9)2.9 (0.8)Number of metabolic abnormalities, mean (SD)
133.3 (14.9)130.8 (15.2)131.8 (15.8)Systolic blood pressure (mmHg), mean (SD)
89.0 (11.7)86.6 (10.7)87.4 (9.9)Diastolic blood pressure (mmHg) , mean (SD)
164.0 (8.9)165.3 (10.4)166.4 (8.8)Height (cm), mean (SD)
71.9 (11.6)72.6 (12.4)71.8 (13.2)Weight (kg, mean (SD)
26.6 (2.9)26.5 (3.2)25.8 (2.8)Body mass index (kg/m2), mean (SD)
90.4 (7.0)90.8 (8.2)89.1 (8.2)Waist circumference (cm) , mean (SD)
31.6 (5.7)31.9 (7.1)30.3 (6.8)Percent body fat, mean (SD)
22.5 (4.5)23.1 (6.4)21.5 (5.2)Fat mass (kg), mean (SD)
27.5 (6.1)27.6 (6.2)28.1 (7.1)Skeletal muscle mass (kg) , mean (SD)
205.1 (31.8)197.4 (34.1)212.9 (31.6)Total cholesterol (mg/dL), mean (SD)
169.2 (72.7)176.6 (107.7)212.9 (138.0)Triglyceride (mg/dL), mean (SD)
46.3 (10.5)47.1 (11.2)46.1 (8.4)HDLa cholesterol (mg/dL), mean (SD)
137.1 (30.7)127.5 (35.0)139.1 (28.8)LDLb cholesterol (mg/dL), mean (SD)
98.9 (19.0)105.9 (39.4)98.1 (13.8)Fasting blood glucose (mg/dL), mean (SD)
11.8 (3.9)11.5 (4.8)11.4 (4.8)Insulin (mIU/mL), mean (SD)
5.8 (0.7)6.1 (1.2)5.9 (0.7)Hemoglobin A1c (%), mean (SD)
2.9 (1.5)3.0 (1.5)2.8 (1.2)HOMA-IRc, mean (SD)
1 (2.3)2 (4.4)2 (4.9)Hypertension, mean (SD)
0 (0.0)0 (0.0)0 (0.0)Diabetes, mean (SD)
1 (2.3)1 (2.2)3 (7.3)Dyslipidemia, mean (SD)
Smoking status, n (%)
25 (58.1)28 (62.2)19 (46.3)Never
11 (25.6)11 (24.4)8 (19.5)Former
7 (16.3)6 (13.3)14 (34.2)Current
Alcohol consumption, n (%)
5 (11.6)8 (17.8)5 (12.2)Never
2 (4.7)0 (0.0)2 (4.9)Former
36 (83.7)37 (82.2)34 (82.9)Current
11.5 (18.1)10.4 (15.5)22.1 (38.8)Alcohol consumption (g/day), mean (SD)
MVPAd engagement, n (%)
9 (20.9)8 (17.8)2 (4.9)Yes
34 (79.1)37 (82.2)39 (95.1)No
7.1 (3.9)6.6 (2.8)7.2 (2.7)Sedentary time (hours/day), mean (SD)
aHDL: high-density lipoprotein.
bLDL: low-density lipoprotein.
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cHOMA-IR: homeostatic model assessment of insulin resistance.
dMVPA: moderate-vigorous physical activity.
To ensure homogeneity between those who attended and those
who did not attend follow-up at least once, we have compared
the baseline characteristics as illustrated in Multimedia
Appendix 1. In regard to age, sex, anthropometry, and glycemic
and lipid profiles, no statistically significant differences (age:
P=.10; sex: P=.09; systolic blood pressure: P=.36; diastolic
blood pressure: P=.93; BMI: P=.98; total cholesterol: P=.95;
fasting glucose level: P=.25) were detected between the 2
groups. The only notable difference was the proportion of
current smokers; those who did not attend any follow-up
examinations had a higher proportion of current smokers than
those who attended at least once (44.4% versus 17.1%; P=.04;
Multimedia Appendix 2).
Comparisons at Each Time Point
All 3 groups showed varying amounts of systolic blood pressure
reduction overall. In reference to the baseline examination, the
control and app only groups showed the most dramatic reduction
at week 24 (control: mean –10.95, SD 11.98 mmHg; app only:
mean –7.19, SD 9.98 mmHg), whereas the app with personalized
coaching group showed the most dramatic systolic blood
pressure reduction at week 12 (mean –7.82, SD 11.98 mmHg).
However, compared to the control group, neither the app only
nor the app with personalized coaching group had significantly
different systolic blood pressure change at any follow-up
examination (Figure 3).
For secondary outcomes, participants in the app with
personalized coaching group generally lost more body weight
(mean –0.96 kg versus –0.12 kg; Figure 4), lost more body fat
mass (mean –0.79 kg versus 0.13 kg; Figure 5), and had smaller
waist circumferences (mean –1.86 cm versus –0.08 cm;
Multimedia Appendix 2) by the end of the study period. At
week 24, diastolic blood pressure (P=.42; Multimedia Appendix
3) and other glycemic (fasting glucose level: P=.99; HOMA-IR:
P=.63; Multimedia Appendix 4 and Multimedia Appendix 5,
respectively), and lipid indices (triglyceride level: P=.93; HDL
cholesterol level: P=.46; Multimedia Appendix 6 and
Multimedia Appendix 7, respectively) had not changed
significantly.
Figure 3. Systolic blood pressure changes from the baseline across the 3 groups at each time point. AO: app-only; APC: app with personalized coaching;
CO: control, SBP: systolic blood pressure.
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Figure 4. Body weight changes from the baseline across the 3 groups at each time point. AO: app-only; APC: app with personalized coaching; CO:
control, SBP: systolic blood pressure.
Figure 5. Body fat mass changes from the baseline across the 3 groups at each time point. AO: app-only; APC: app with personalized coaching; CO:
control.
Linear Mixed Model
Neither the app only (control versus app only at week 24:
β=2.93, SE 2.42, P=.23) nor the app and additional personalized
feedback feature (control versus app with personalized coaching
at week 24: β=3.18, SE 2.42, P=.19) significantly contributed
to systolic blood pressure reduction at any of the follow-up
examinations (Multimedia Appendix 1). In regard to secondary
outcomes, statistically significant effects were observed for
body weight and body fat. Compared to the participants in the
control group, those in the app with personalized coaching group
lost more body weight at week 12 (β=–0.93, SE 0.43; P=.03)
and at week 24 (β=–0.87, SE 0.42; P=.04). This translated to
an average difference of 0.14 kg of body weight loss per month
between participants in the control group and participants in
the app with personalized coaching group. In parallel, the app
with personalized coaching group lost more body fat than the
control group did at week 24 (β=–0.95, SE 0.46, P=.04). This
was equivalent to participants in the app with personalized
coaching group losing an average of 0.19 kg more body fat per
month than those in the control group. The app with personalized
coaching group showed significant HOMA-IR level reductions
at week 12 (β=–0.55, SE 0.27, P=.04). However, separate
examination by fasting glucose level did not show significance
(P=.80) and the HOMA-IR reductions diminished by week 24
(β=–0.22, SE 0.26, P=.40). Otherwise, there were no significant
effects of the app on diastolic blood pressure (app only: P=.83;
app with personalized coaching group: P=.47), waist
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circumference (app only: P=.32; app with personalized
coaching: P=.12), triglyceride (app only: P=.70; app with
personalized coaching: P=.23), HDL cholesterol (app only:
P=.14; app with personalized coaching: P=.91), or fasting blood
glucose level (app only: P=.38; app with personalized coaching:
P=.84; Multimedia Appendix 1).
Discussion
Principal Findings
Mobile-based behavioral health interventions that permit
real-time data collection and sharing are increasingly
commonplace, enabling researchers to assess multiple health
behaviors in various contexts. At the same time, they prompt
users to be more self-aware and to modify their own health
behavior. In this context, the goal behind this study was to assess
the real-world effectiveness of a smartphone-based
self-monitoring health management app in a
community-dwelling population of individuals without diagnosis
or treatment of metabolic disorders. App usage showed
differential effects on metabolic parameters at different time
points. Overall, the primary outcome of systolic blood pressure
followed a decreasing trend from the baseline yet did not change
notably between the 3 groups at any follow-up examinations.
Instead, the simultaneous diet/exercise logging and lifestyle
coaching yielded relatively greater body weight reduction,
specifically via body fat mass reduction. These effects were
attenuated yet sustained at 6 month.
Despite no significant systolic blood pressure improvement in
this study, previous studies [12-14,22-24] have identified the
utility of mobile apps in lowering blood pressure through
self-monitoring and information delivery services. In several
randomized controlled trials [12-14,22-24] conducted in obesity
clinic settings, text messages or emails for antihypertensive
medication adherence, tailored guidance on salt intake, smoking
cessation, and physical activity interventions reported significant
differences in blood pressure reduction compared to usual care.
However, unlike our study in which community-dwelling
individuals without overt metabolic syndrome participated,
similar studies [7,21,25] have been primarily performed on
patients based on completers’ analysis rather than
intention-to-treat. Considering varied levels of initiative for
health management often used as a proxy for adherence and
attrition, our results indicate that effectiveness of these self-care
apps may considerably differ by study population and analytical
methods.
Moreover, Liu and colleagues’ [25] examination of
internet-based counseling interventions among patients with
elevated blood pressure indicated that e-counseling interventions
significantly reduced daytime systolic blood pressure by 3.8
mmHg (95% CI −5.63 to −2.06), with greater reductions from
more sustained interventions. Since our study relied on a
single-occasion blood pressure measurement in the examination
setting, the results may potentially be distorted by whitecoat or
masked hypertension.
Furthermore, a significant limitation of accumulated evidence
is that many studies [7] were conducted for durations less than
6 months. Given that hypertension is a chronic condition that
requires long-term pharmacological treatment and lifestyle
modification, prolonged observation should be allotted for more
accurate assessment of intervention adherence and subsequent
blood pressure changes.
In our study, body weight reduction, via body fat mass loss,
was the most evident improvement from app usage, as indicated
by similar trials [26,27]. Among overweight adults, daily
transmitted personalized multimedia message services providing
weight control materials have proven to induce greater weight
loss (−1.97 kg difference, 95% CI −0.34 to −3.60 kg) than the
non-receiving group [26]. A systematic review [25] consistently
identified the association between self-monitoring or online
obesity treatment programs and body size reduction via targeted
advice on reduced energy intake, increased physical activity,
and social support. Often, the studies incorporated the use of
structured regimen, regular self-monitoring, circumstantially
appropriate feedback, prompt communication, and social support
[27]. Abraham et al [28] classified such intervention content,
including information-motivation-behavior skills model (ie,
providing information about behavior-health link),
social-cognitive theory (ie, prompting barrier identification,
general encouragement), control therapy (ie, self-monitoring,
interactive feedback), relapse prevention and behavior
sustenance, and more. Although the extent and nature of the
interventions varied across studies, these elements commonly
found in mobile technology interventions, altogether, appear
crucial in driving greater changes.
Our study results indicated that the 6-month usage of the mobile
app did not substantially improve insulin sensitivity. Yet, an
analogous meta-analysis [29] demonstrated that comprehensive
lifestyle modification delivered through a mobile app lowered
hemoglobin A1c level by an average of 0.5% over 6 months of
follow-up. Interestingly, this decrease was not accompanied by
concurrent improvements in other diabetes risk factors, such as
blood pressure, cholesterol levels, or adiposity [29]. However,
considering that hemoglobin A1c reflects long-term fluctuations
of glycemic control (unlike fasting glucose level used in our
study), Liang et al [29] raised concerns regarding insufficient
follow-up period. Moreover, since these trials were conducted
on persons diagnosed with diabetes of varying subtypes and
adherence to antihyperglycemic treatments, it would have been
challenging to isolate the effectiveness of the mobile app
intervention from changes in treatment behavior. Therefore, the
different representation of glycemic state and participant
characteristics warrant caution in assuming or denying the
attribution of these technology-based intervention to other
nonspecific benefits.
Over the span of 6 months, our participants did not show
significantly different changes in triglyceride and HDL
cholesterol levels across the 3 groups. Yet, Park and Kim [30]
showed that, among gynecology and family medicine
outpatients, the use of web-based diet and exercise diaries and
the specialists’ weekly lifestyle modification recommendations
improved total (–12.9 mg/dL) and low-density lipoprotein (–11.3
mg/dL) cholesterol levels after 12 weeks. Again, it is hard to
extrapolate from clinic setting population in which individuals
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may already be utilizing health management app prior to trial
entrance or may be taking medications (ie, statins) that distort
the true effects of the interventions.
The greatest novelty of our study lies in its evaluation of the
mobile app’s effectiveness via intention-to-treat approach in
nonpatient population without the concern of confounding by
pharmacological treatment. Considering that the general
population consists of individuals with wide-ranging levels of
digital literacy and utility, willingness for lifestyle modification,
and physiological and socioeconomic backgrounds, our study
portrays the effectiveness of mobile-based health management
app in real-world setting. Furthermore, the assessor-blinding
enabled true compliance assessment in the sample regardless
of individual preference for or competency with the app, thereby
evaluating the app’s real-world potential. In addition, because
we assessed the changes in metabolic parameters repeatedly
over a considerable time horizon, our results reflect the
long-term trajectory of the metabolic indices, empirically.
Lastly, as a 3-arm parallel design with concurrent control, we
were able to discriminate whether the self-logging of diet and
exercise was sufficient to induce improvements in metabolic
parameter or whether additional personalized coaching was the
critical element in shaping healthy behavior.
Nonetheless, several limitations warrant cautious interpretation
of our study findings. During the screening test, we faced an
unexpectedly greater number of participants who did not satisfy
the inclusion criteria, and thus, we were unable to reach the goal
sample size. During the study period, because the participants
had varying attendance to each of the follow-up examination,
there may have been residual heterogeneity among participants
who attended follow-up examinations none, once, twice, or all
follow-up examinations. Yet, those lost to follow-up were
demographically similar to those who participated in the study
with the exception of current smoking status. If any effects were
present, we expect such attrition to have an effect on the study
results toward the null. Moreover, because the participants were
selected from an already-established cohort, higher self-efficacy
and proficiency may have been present. Therefore, the results
may not be entirely generalizable to the general population.
However, the original cohort study was purely observational;
thus, our findings still represent individuals typically seeking
health management without referral to physician nor
pharmacological treatment. Furthermore, similar literature has
suggested that baseline self-efficacy appraisals may not be
entirely pertinent to practical skills or opportunities to sustain
life changes [15]. In this context, we expect comparable
initiatives for lifestyle modification between our study and the
general population. Lastly, considering that blood pressure,
body size, glycemic index, and lipid indices are reflective of
chronic states, our 6-month study period may have been
insufficient to witness changes. Future studies with a larger
sample size and a prolonged study period may better assess the
effectiveness of lifestyle modification mobile apps on the
long-term trajectory of metabolic indices.
Conclusions
Among the community-dwelling adults with moderate metabolic
abnormalities without diagnosis or treatment for disorders, we
examined the effect of a smartphone-based app on changes in
metabolic parameters. By the end of the 6-month study period,
no changes to systolic blood pressure were significant for
participants who utilized both diet/exercise logging and
personalized coaching compared to logging-only or nonusing
groups. Instead, the self-logging and lifestyle coaching yielded
greater body weight reduction via body fat mass loss. The
research investigating mobile health management interventions
that confer accessible and cost-effective benefits remains in its
infancy, especially in general populations. Future studies
focusing on comparative effectiveness using alternative study
designs and on populations of various health, socioeconomic,
and cultural backgrounds are needed to integrate these apps in
everyday lives and clinic practice.
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